Federal prosecutors in Oklahoma are conducting a criminal investigation of a Pfizer unit's promotional practices for organ-transplant drug Rapamune, the drug maker disclosed Friday.
New York-based Pfizer said in a regulatory filing the U.S. Attorney's office for the western district of Oklahoma was conducting the probe. There were no further details in the regulatory filing; a Pfizer spokesman declined immediate comment.
Officials at the U.S. Attorney's office in Oklahoma City couldn't immediately be reached.
Rapamune is an immunosuppressant used to prevent the body's rejection of transplanted kidneys. Pfizer acquired the drug with its purchase of Wyeth last year.
Source
2 comments:
Anyone know anything about the availability of Rapamune now. My son needs it and it has worked miracles for him and our pharmacy is unable to obtain it. HELP!!!
I am a retired physician with a kidney transplant and, along with other immunosuppressants, take Rapamune daily.
I have Aetna-Medicare health insurance with prescription benefits wherein a copayment is required.
After Wyeth was acquired by Pfizer, my copayment for three months supply of Rapamune rose sharply from around $120 to $460.
Is Pfizer financing its acquisition by raising prices on all of Wyeth's patented medicines??
Post a Comment